Clonidine
Discover related
5 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Alpha-1D adrenergic receptor (Adra1d) | Agonist | 6.9 Ki | DRUGCENTRAL | TargetAlpha-1D adrenergic receptor (Adra1d) ActionAgonist Affinity6.9 Ki SourceDRUGCENTRAL |
| Alpha-2A adrenergic receptor (ADRA2A) | Agonist | 8.42 Ki | DRUGCENTRAL | TargetAlpha-2A adrenergic receptor (ADRA2A) ActionAgonist Affinity8.42 Ki SourceDRUGCENTRAL |
| Alpha-2B adrenergic receptor (ADRA2B) | Agonist | 7.5 Ki | DRUGCENTRAL | TargetAlpha-2B adrenergic receptor (ADRA2B) ActionAgonist Affinity7.5 Ki SourceDRUGCENTRAL |
| Alpha-2C adrenergic receptor (ADRA2C) | Agonist | 6.7 EC50 | DRUGCENTRAL | TargetAlpha-2C adrenergic receptor (ADRA2C) ActionAgonist Affinity6.7 EC50 SourceDRUGCENTRAL |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Hcn1) | Blocker | 4.4 IC50 | DRUGCENTRAL | TargetPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Hcn1) ActionBlocker Affinity4.4 IC50 SourceDRUGCENTRAL |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Hcn2) | Blocker | 5.1 IC50 | DRUGCENTRAL | TargetPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Hcn2) ActionBlocker Affinity5.1 IC50 SourceDRUGCENTRAL |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 (Hcn4) | Blocker | 5 IC50 | DRUGCENTRAL | TargetPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 (Hcn4) ActionBlocker Affinity5 IC50 SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 1A (HTR1A) | — | 5.49 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 1A (HTR1A) Action— Affinity5.49 Ki SourceDRUGCENTRAL |
| Adrenergic receptor alpha-2 (Adra2b) | — | 8.82 Ki | DRUGCENTRAL | TargetAdrenergic receptor alpha-2 (Adra2b) Action— Affinity8.82 Ki SourceDRUGCENTRAL |
| Alpha-1A adrenergic receptor (ADRA1A) | — | 6.5 Ki | DRUGCENTRAL | TargetAlpha-1A adrenergic receptor (ADRA1A) Action— Affinity6.5 Ki SourceDRUGCENTRAL |
| Alpha-1B adrenergic receptor (ADRA1B) | — | 6.5 Ki | DRUGCENTRAL | TargetAlpha-1B adrenergic receptor (ADRA1B) Action— Affinity6.5 Ki SourceDRUGCENTRAL |
| Alpha-1D adrenergic receptor (ADRA1D) | — | 6.22 Ki | DRUGCENTRAL | TargetAlpha-1D adrenergic receptor (ADRA1D) Action— Affinity6.22 Ki SourceDRUGCENTRAL |
| Alpha-2A adrenergic receptor (Adra2a) | — | 9.41 Ki | DRUGCENTRAL | TargetAlpha-2A adrenergic receptor (Adra2a) Action— Affinity9.41 Ki SourceDRUGCENTRAL |
| Alpha-2B adrenergic receptor (Adra2b) | — | 8.08 Ki | DRUGCENTRAL | TargetAlpha-2B adrenergic receptor (Adra2b) Action— Affinity8.08 Ki SourceDRUGCENTRAL |
| Beta-1 adrenergic receptor (ADRB1) | — | 4.4 Kd | DRUGCENTRAL | TargetBeta-1 adrenergic receptor (ADRB1) Action— Affinity4.4 Kd SourceDRUGCENTRAL |
| Multidrug and toxin extrusion protein 1 (SLC47A1) | — | 4.48 IC50 | DRUGCENTRAL | TargetMultidrug and toxin extrusion protein 1 (SLC47A1) Action— Affinity4.48 IC50 SourceDRUGCENTRAL |
| Nischarin (NISCH) | — | 8.05 Ki | DRUGCENTRAL | TargetNischarin (NISCH) Action— Affinity8.05 Ki SourceDRUGCENTRAL |
| Solute carrier family 22 member 1 (SLC22A1) | — | 4.65 IC50 | DRUGCENTRAL | TargetSolute carrier family 22 member 1 (SLC22A1) Action— Affinity4.65 IC50 SourceDRUGCENTRAL |
| Solute carrier family 22 member 2 (SLC22A2) | — | 4.796 IC50 | DRUGCENTRAL | TargetSolute carrier family 22 member 2 (SLC22A2) Action— Affinity4.796 IC50 SourceDRUGCENTRAL |
External links
PubChem 2803 ↗CAS 4205-90-7 ↗CAS 4205-91-8 ↗ChEBI CHEBI:3757 ↗ChEBI CHEBI:46632 ↗ChEMBL CHEMBL134 ↗KEGG D00281 ↗DrugBank DB00575 ↗NIH ↗ChemSpider ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗CAS 54707-71-0 ↗CAS 92755-66-3 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Clonidine ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.